Target intelligence / Profile preview

Coxsackievirus A6

Molecular classification: Virus, Enterovirus, Picornaviridae

Overview

Coxsackievirus A6 (CVA6) is a member of the Enterovirus genus within the Picornaviridae family. It is a non-enveloped, positive-sense single-stranded RNA virus. CVA6 has emerged as an important human pathogen, particularly noted for causing outbreaks of hand, foot, and mouth disease (HFMD), often with atypical or more severe presentations compared to other enteroviruses.

Other names: CVA6

Mechanism of action

No specific antiviral therapy exists; management remains supportive. Preventive measures focus on hygiene practices to limit transmission.

Biological functions

Viral replicationHost cell infectionInduction of immune response

Disease associations

Hand, foot, and mouth disease (HFMD)MeningitisPulmonary edema

Beyond the preview

Go deeper on Coxsackievirus A6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coxsackievirus A6.

Explore the full profile